Poland· PL-100403918
Alofisel
A darvadstrocel product containing darvadstrocelum, registered in Poland by Takeda Pharma A/S. The same ATC class is registered in 7 of our 19 countries.
Checked against URPL (Poland) on
Informational only — not a medical device.
Where it is registered
Darvadstrocel is registered in 7 of 19 countries.
Countries holding a registration under ATC L04AX08 (darvadstrocel), each read from that country’s own register.
- This record: Poland, from URPL (Poland)
- 5 of them publish a price we can compare per daily dose
Darvadstrocel · ATC L04AX08
7 / 19 countries
- Belgiumprice
- Finlandprice
- Franceprice
- Japan
- Polandprice
- Spainprice
- United Kingdom
The record
At a glance
URPL (Poland)- Active substance
- Darvadstrocelum
- Manufacturer
- Takeda Pharma A/S
- Country
- Poland (PL)
- ATC code
- L04AX08
- ATC class
- Darvadstrocel
- Reimbursed
- Not published by this register
- Source register
- URPL (Poland)
- Last checked
- September 27, 2026
Packs & prices · 1
- gtin05909991426330
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Same medicine, other countries
Darvadstrocel in 5 other countries
What each register calls a product with the same active substance — salts and hydrates count as the same.
- BelgiumAlofisel 5 10*6 cells/mlTakeda Pharma
- SpainALOFISEL 5 × 10E6 CÉLULAS/ML DISPERSION INYECTABLETakeda Pharma A/S
- FinlandAlofiselTakeda Pharma A/S
- FranceALOFISEL 5 millions de cellules/ml, suspension injectableTAKEDA PHARMA (DANEMARK)
- United KingdomAlofisel 30million cells/6ml dispersion for injection vialsTakeda UK Ltd
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of URPL (Poland). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/7d18fb50-9e37-4558-930d-b54b3493384a GET /v1/drugs/7d18fb50-9e37-4558-930d-b54b3493384a?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"form": "Zawiesina do wstrzykiwań",
"source": "urpl",
"strength": "5 mln komórek/ml",
"packaging": "05909991426330 ¦ Rpz ¦ EU/1/17/1261/001 ¦ 127681\n4 fiol. 6 ml",
"substance": "Darvadstrocelum 5 mln komórek/ml",
"common_name": "Darvadstrocelum",
"pl_product_id": "100403918",
"pozwolenie_nr": null,
"auth_procedure": "CEN",
"authorisation_validity": "2024-12-14"
}See everything about darvadstrocel.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.